In other words, not only are AMPK, CNBP, and ODC1 genes frequently gained in medulloblastoma, but these gains tend to co-occur more often than expected at random, suggesting that the co-occurrence of these gains may provide a synergistic advantage. The gene discussed is PRKAA1; the disease is medulloblastoma.